Addressing the Rising Costs of Insulin: What's the Best Way to Keep Prices Down?
This Week in Business
00:00
The Consumer's View on Insulin Prices
Mark Paul is Professor Emeritus in Healthcare Management at the Wharton School. He says if firms that have monopolies behave like monopolists, and so they charge high prices, it reduces their source of monopoly power. Mark: FDA slowness in approving a generic substitute for insulin was partly to blame.
Transcript
Play full episode
